DBV Technologies S.A. American Depositary Shares

DBVTNASDAQ • USD
9.70 USD
↘ 0.29 (2.87%)AT CLOSE (03:59 PM EST)
9.71
↗ 0.00 (0.02%)
POST MARKET (AS OF 04:00 PM EST)
Post Market
AS OF 04:00 PM EST
9.71
↗ 0.00 (0.02%)
🟢Market: OPEN

DBV Technologies S.A. American Depositary Shares (DBVT) is currently trading at $9.71. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, DBVT is currently richly valued, trading at a premium to sector peers across key valuation metrics.

Technical & fundamental data as of Nov 17, 2026.

Open?$9.92
High?$10.11
Low?$9.61
Prev. Close?$9.99
Volume?124.1K
Avg. Volume?390.1K
VWAP?$9.86
Rel. Volume?0.32x
Bid / Ask
Bid?$8.41 × 100
Ask?$11.23 × 100
Spread?$2.82
Midpoint?$9.82
Valuation & Ratios
Market Cap?627.8M
Shares Out?62.9M
P/E Ratio?N/A
P/B Ratio?4.22
EPS?-$3.30
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.
Employees
179
Market Cap
627.8M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2014-10-22
Address
107 AVENUE DE LA REPUBLIQUE
CHATILLON,
Phone: 330155427878
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
6
Z-Score?
11
Momentum?
50
Short Sent.?
51
Piotroski F-Score?1/9Weak
Altman Z-Score?1.03Distress
Confidence?64%Moderate
Full Fundamental Analysis →
Short InterestLow
Short Interest?806.7K
Days to Cover?1.7
Avg Daily Volume483.6K
Settlement Date2026-10-30
Financial Health
Current Ratio?3.24Strong
Quick Ratio?3.24Strong
Cash Ratio?2.83Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
58/100
P/E?
N/A▾
P/B?
Peers
100
S&P
42
4.22FAIR▾
P/S?
Peers
100
S&P
3
163.27HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.3CHEAP▾
EV/Sales?
Peers
100
S&P
3
120.23HIGH▾
Returns & Efficiency
ROE?
S&P
3
-139.4%WEAK▾
ROA?
S&P
3
-96.3%WEAK▾
Cash Flow & Enterprise
FCF?$-191746000
Enterprise Value?$462.3M
Fundamentals ratios updated end of day